Figure five: Conolidine is antinociceptive in visceral, tonic and persistent discomfort types and is current at micromolar concentrations from the brain after systemic injection. Conolidine CONOCB2™ in essence is effective by making a barrier amongst the opioid receptors while in the brain plus the "scavenger" receptors in the human https://annd172lsa7.blogsuperapp.com/profile